We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+7.85%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.76B
AUM Growth
+$1.71M
Cap. Flow
-$65.7M
Cap. Flow %
-3.73%
Top 10 Hldgs %
24.81%
Holding
276
New
14
Increased
59
Reduced
180
Closed
14

Top Buys

Rank Stock Value
1
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$15M
2
EB
Eventbrite
EB
+$9.72M
3
ESTA icon
Establishment Labs
ESTA
+$9.35M
4
PRO
PROS Holdings
PRO
+$7.11M
5
PCRX icon
Pacira BioSciences
PCRX
+$6.75M

Top Sells

Rank Stock Value
1
SMTC icon
Semtech
SMTC
+$13.7M
2
MED icon
Medifast
MED
+$11.8M
3
PINC
Premier
PINC
+$11M
4
RVNC
Revance Therapeutics, Inc.
RVNC
+$8M
5
MEDP icon
Medpace
MEDP
+$7.15M

Sector Composition

Rank Sector Weight
1 Healthcare 28.23%
2 Technology 24.76%
3 Industrials 19.11%
4 Consumer Discretionary 9.18%
5 Communication Services 6.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVDA icon
201
NVIDIA
NVDA
$5.42T
$1.3M 0.07%
30,800
-45,420
-60% -$1.51M
BRKR icon
202
Bruker
BRKR
$8.14B
$1.3M 0.07%
17,524
-13,440
-43% -$1.02M
SMLR
203
DELISTED
Semler Scientific
SMLR
$1.29M 0.07%
49,101
-44,101
-47% -$1.16M
FLWS icon
204
1-800-Flowers.com
FLWS
$258M
$1.27M 0.07%
162,911
+6,183
+4% +$56.8K
TVTX icon
205
Travere Therapeutics
TVTX
$5.78B
$1.23M 0.07%
79,843
+3,345
+4% +$60.8K
CERS icon
206
Cerus
CERS
$474M
$1.19M 0.07%
485,768
-57,273
-11% -$136K
OPTN
207
DELISTED
OptiNose
OPTN
$1.19M 0.07%
64,448
+12,984
+25% +$307K
TECH icon
208
Bio-Techne
TECH
$11.3B
$1.18M 0.07%
14,440
-8,014
-36% -$644K
FMC icon
209
FMC
FMC
$1.33B
$1.17M 0.07%
11,216
-6,015
-35% -$676K
GNTY
210
DELISTED
Guaranty Bancshares
GNTY
$1.11M 0.06%
40,891
-4,621
-10% -$117K
THS
211
DELISTED
Treehouse Foods
THS
$1.1M 0.06%
21,863
-15,032
-41% -$771K
EW icon
212
Edwards Lifesciences
EW
$51.7B
$1.1M 0.06%
11,649
-8,128
-41% -$706K
AAP icon
213
Advance Auto Parts
AAP
$3.49B
$1.04M 0.06%
14,850
-647
-4% -$66.6K
SMID icon
214
Smith-Midland
SMID
$152M
$1.03M 0.06%
43,974
+1,645
+4% +$30K
ASPN icon
215
Aspen Aerogels
ASPN
$518M
$1.01M 0.06%
+128,473
New +$894K
BRK.B icon
216
Berkshire Hathaway Class B
BRK.B
$1.13T
$1.01M 0.06%
2,950
-5
-0.2% -$1.63K
KNX icon
217
Knight Transportation
KNX
$11.4B
$993K 0.06%
17,877
-15,534
-46% -$867K
DENN
218
DELISTED
Denny's
DENN
$977K 0.06%
79,274
+3,087
+4% +$35K
LTHM
219
DELISTED
Livent Corporation
LTHM
$968K 0.05%
+35,279
New +$846K
DOV icon
220
Dover
DOV
$28.4B
$920K 0.05%
6,229
-6,015
-49% -$860K
LLY icon
221
Eli Lilly
LLY
$1.06T
$910K 0.05%
1,940
-50
-3% -$21K
KBR icon
222
KBR
KBR
$4.8B
$884K 0.05%
13,587
-10,000
-42% -$596K
CR icon
223
Crane Co
CR
$12.7B
$866K 0.05%
+9,713
New +$750K
EBAY icon
224
eBay
EBAY
$49.8B
$844K 0.05%
18,884
-12,000
-39% -$533K
TTC icon
225
Toro Company
TTC
$9.49B
$823K 0.05%
8,095
-5,420
-40% -$556K
7 8
9
10 11

Similar funds

WFMPM
Woodley Farra Manion Portfolio Management Indianapolis, Indiana $2.05B AUM 14.54% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SW
SoFi Wealth San Francisco, California $2.08B AUM 18.22% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return

Rice Hall James & Associates's Q2 2023 Portfolio in Review

As of Q2 2023, Rice Hall James & Associates held 276 positions worth $1.76B, up 0.1% from $1.76B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Rice Hall James & Associates withdrew a net $65.7M in Q2 2023, closing 14 positions and reducing 180 holdings. Its most notable exit was Semtech, an estimated $13.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 27% a quarter earlier, followed by Technology and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in BioCryst Pharmaceuticals worth $13.2M.

  • Rice Hall James & Associates's largest Q2 2023 buy was BioCryst Pharmaceuticals: 1,872,964 shares worth $13.2M.
  • Rice Hall James & Associates added most to Eventbrite in Q2 2023, an estimated $9.72M increase.
  • Rice Hall James & Associates's biggest Q2 2023 reduction was Premier, cutting an estimated $11M.
  • Rice Hall James & Associates fully exited Semtech in Q2 2023, selling an estimated $13.7M.
  • Rice Hall James & Associates's ten largest holdings make up 25% of its $1.76B portfolio in Q2 2023.
  • Rice Hall James & Associates opened 14 new positions and closed 14 in Q2 2023.
  • Rice Hall James & Associates's portfolio value rose 0.1% quarter-over-quarter to $1.76B.

Based on Rice Hall James & Associates's 13F filing for Q2 2023, filed 24 Jul 2023.